EBG00000313325 - n.1126G>T
Drug resistance types
7 Sensitive
0 RR-TB
1 HR-TB
1 MDR-TB
2 Pre-XDR-TB
0 XDR-TB
17 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage4.1.2.1 | 1 |
| lineage2.2.1 | 12 |
| lineage2.2.2 | 1 |
| lineage1.1.3.2 | 1 |
| lineage4.9 | 2 |
| lineage4.4.1.1.1 | 1 |
| lineage2.1 | 1 |
| lineage6.2.3 | 1 |
| lineage1.2.2.2 | 1 |
| La1.8.1 | 3 |
| lineage4.3.3 | 2 |
| lineage2.2.1;lineage4 | 1 |
| lineage4.8 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 28 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 | SRR18149455 | Sensitive | lineage4.1.2.1 | None | SRR16295746 | Other | lineage2.2.1 | None | SRR10869086 | Pre-XDR-TB | lineage2.2.2 | None | ERR9029360 | MDR-TB | lineage2.2.1 | None | ERR2660524 | HR-TB | lineage1.1.3.2 | None | ERR4769549 | Sensitive | lineage4.9 | None | SRR16295824 | Other | lineage2.2.1 | None | SRR16295763 | Other | lineage2.2.1 | None | SRR16295819 | Other | lineage2.2.1 | None | SRR2101659 | Other | lineage4.4.1.1.1 | None | SRR11662417 | Pre-XDR-TB | lineage2.1 | None | ERR10796630 | Other | lineage6.2.3 | None | SRR16295813 | Other | lineage2.2.1 | None | SRR16295826 | Other | lineage2.2.1 | None | SRR19576436 | Sensitive | lineage1.2.2.2 | None | ERR4188381 | Other | La1.8.1 | None | SRR16295777 | Other | lineage2.2.1 | None | SRR6982174 | Sensitive | lineage4.3.3 | None | SRR16295775 | Other | lineage2.2.1 | None | ERR4188021 | Other | La1.8.1 | None | SRR11972311 | Other | lineage2.2.1;lineage4 | None | ERR4188395 | Sensitive | La1.8.1 | None | SRR16295830 | Other | lineage2.2.1 | None | SRR16295811 | Other | lineage2.2.1 | None | SRR21764250 | Other | lineage4.9 | None | ERR6866186 | Sensitive | lineage4.8 | None | SRR16295770 | Other | lineage2.2.1 | None | SRR2101662 | Sensitive | lineage4.3.3 | None |
|---|
